{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:10:23Z","timestamp":1789744223954,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shenzhen protgen Co., Ltd."},{"name":"Shenzhen protgen C.,Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In this multicenter, randomized, double-blind, active-controlled phase 3 trial (NCT06553456), we assessed the equivalence of recombinant human serum albumin (rHSA) expressed in\n                    <jats:italic>Pichia pastoris<\/jats:italic>\n                    to plasma-derived human serum albumin (pHSA) for elevating serum albumin (ALB) levels and non-inferiority regarding ascites improvement in patients with cirrhotic ascites. Using a rigorous dual-endpoint design, the primary endpoint was the change from baseline in serum ALB immediately after the final intravenous infusion. The key secondary endpoint was the ascites improvement rate after the final administration. Ultimately, 364 out of 390 patients completed the study. Statistical equivalence was established for the primary endpoint, with least-squares mean ALB changes of 11.16\u2009\u00b1\u20090.364\u2009g\/L (rHSA) and 10.95\u2009\u00b1\u20090.395\u2009g\/L (pHSA) (LSM difference: 0.21\u2009g\/L [95% CI: \u22120.75, 1.16]). For the secondary endpoint, ascites improvement was non-inferior, demonstrating a 58.0% response rate for rHSA versus 48.7% for pHSA (difference: 9.4% [95% CI: \u22120.56%, 19.10%]). Both endpoints of the trial were successfully achieved. The overall incidence of adverse events was similar in the two groups; crucially, no anti-drug antibodies were detected in the rHSA group. Exploratory analysis revealed that rHSA significantly reduced glycated ALB (\u221212.24%), whereas pHSA increased it (\u2009+\u200912.52%) (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). Corroborated by LC\u2012MS characterization, silver-staining purity assessment, and four biochemical quality attributes (free thiol, Hcy, AGEs, and carbonyl levels), this divergence highlights the preserved molecular integrity of rHSA. This trial demonstrated that in patients with cirrhotic ascites, rHSA was statistically equivalent to pHSA in elevating serum ALB and non-inferior in ascites improvement, with a favorable safety profile.\n                  <\/jats:p>","DOI":"10.1038\/s41392-026-02951-7","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:38:16Z","timestamp":1789742296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A randomized, double-blind, active-controlled phase 3 multicenter trial of rHSA for cirrhotic ascites"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-8890","authenticated-orcid":false,"given":"Jidong","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanfang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongji","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolian","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanzhou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuilin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingguo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongkuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengzhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"2951_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","volume":"61","author":"V Arroyo","year":"2014","unstructured":"Arroyo, V., Garcia-Martinez, R. & Salvatella, X. Human serum albumin, systemic inflammation, and cirrhosis. J. Hepatol. 61, 396\u2013407 (2014).","journal-title":"J. Hepatol."},{"key":"2951_CR2","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3390\/jcm15051981","volume":"15","author":"I Rubio-Baines","year":"2026","unstructured":"Rubio-Baines, I. et al. Use of human serum albumin in critically ill patients: a narrative review. J. Clin. Med. 15, 1981 (2026).","journal-title":"J. Clin. Med."},{"key":"2951_CR3","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1016\/S2352-3026(19)30200-5","volume":"6","author":"N Roberts","year":"2019","unstructured":"Roberts, N., James, S., Delaney, M. & Fitzmaurice, C. The global need and availability of blood products: a modelling study. Lancet Haematol. 6, e606\u2013e615 (2019).","journal-title":"Lancet Haematol."},{"key":"2951_CR4","unstructured":"World Health Organization. Guidance on Increasing Supplies of Plasma-derived Medicinal Products in Low-and Middle-Income Countries through Fractionation of Domestic Plasma (World Health Organization, 2021)."},{"key":"2951_CR5","unstructured":"World Health Organization. Blood Safety and Availability. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blood-safety-and-availability (2025)."},{"key":"2951_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/pathogens12020318","volume":"12","author":"A Farrugia","year":"2023","unstructured":"Farrugia, A. The evolution of the safety of plasma products from pathogen transmission\u2014a continuing narrative. Pathogens 12, 318 (2023).","journal-title":"Pathogens"},{"key":"2951_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bsheal.2022.12.004","volume":"5","author":"T Simon","year":"2023","unstructured":"Simon, T., Schumann, P., Bieri, M., Schirner, K. & Widmer, E. Hyperoncotic human albumin solutions for intravenous fluid therapy: Effectiveness of pathogen safety and purification methods, and clinical safety. Biosaf. Health 5, 21\u201329 (2023).","journal-title":"Biosaf. Health"},{"key":"2951_CR8","unstructured":"U.S. Food and Drug Administration. Considerations for the Use of Human- and Animal-derived Materials in the Manufacture of Cell and Gene Therapy and Tissue-engineered Medical Products: Draft Guidance for Industry (U.S. Food and Drug Administration, 2024)."},{"key":"2951_CR9","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1002\/jcp.29583","volume":"235","author":"M Karbalaei","year":"2020","unstructured":"Karbalaei, M., Rezaee, S. A. & Farsiani, H. Pichia pastoris: a highly successful expression system for optimal synthesis of heterologous proteins. J. Cell Physiol. 235, 5867\u20135881 (2020).","journal-title":"J. Cell Physiol."},{"key":"2951_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1389-1723(00)88050-0","volume":"89","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi, K. et al. High-level expression of recombinant human serum albumin from the methylotrophic yeast Pichia pastoris with minimal protease production and activation. J. Biosci. Bioeng. 89, 55\u201361 (2000).","journal-title":"J. Biosci. Bioeng."},{"key":"2951_CR11","doi-asserted-by":"publisher","first-page":"105831","DOI":"10.1016\/j.pep.2021.105831","volume":"181","author":"W Zhu","year":"2021","unstructured":"Zhu, W. et al. Medium optimization for high yield production of human serum albumin in Pichia pastoris and its efficient purification. Protein Expr. Purif. 181, 105831 (2021).","journal-title":"Protein Expr. Purif."},{"key":"2951_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.31083\/j.fbe1602019","volume":"16","author":"Y Unver","year":"2024","unstructured":"Unver, Y. & Dagci, I. Komagataella phaffii (Pichia pastoris) as a powerful yeast expression system for biologics production. Front. Biosci. 16, 19 (2024).","journal-title":"Front. Biosci."},{"key":"2951_CR13","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJMoa2022166","volume":"384","author":"L China","year":"2021","unstructured":"China, L. et al. A randomized trial of albumin infusions in hospitalized patients with cirrhosis. N. Engl. J. Med. 384, 808\u2013817 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2951_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cca.2013.07.013","volume":"425","author":"J Anguizola","year":"2013","unstructured":"Anguizola, J. et al. Review: Glycation of human serum albumin. Clin. Chim. Acta 425, 64\u201376 (2013).","journal-title":"Clin. Chim. Acta"},{"key":"2951_CR15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/biom11081191","volume":"11","author":"J Tang","year":"2021","unstructured":"Tang, J. et al. Young and undamaged rMSA improves the healthspan and lifespan of mice. Biomolecules 11, 1191 (2021).","journal-title":"Biomolecules"},{"key":"2951_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03957-3","volume":"21","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Young and undamaged recombinant albumin alleviates T2DM by improving hepatic glycolysis through EGFR and protecting islet beta cells in mice. J. Transl. Med. 21, 89 (2023).","journal-title":"J. Transl. Med."},{"key":"2951_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41392-023-01437-0","volume":"8","author":"B Ma","year":"2023","unstructured":"Ma, B. et al. Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease. Signal. Transduct. Target Ther. 8, 229 (2023).","journal-title":"Signal. Transduct. Target Ther."},{"key":"2951_CR18","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nsb1197-925","volume":"4","author":"Y Luo","year":"1997","unstructured":"Luo, Y., Kay, M. S. & Baldwin, R. L. Cooperativity of folding of the apomyoglobin pH 4 intermediate studied by glycine and proline mutations. Nat. Struct. Biol. 4, 925\u2013930 (1997).","journal-title":"Nat. Struct. Biol."},{"key":"2951_CR19","doi-asserted-by":"publisher","first-page":"11283","DOI":"10.1073\/pnas.96.20.11283","volume":"96","author":"Y Luo","year":"1999","unstructured":"Luo, Y. & Baldwin, R. L. The 28-111 disulfide bond constrains the alpha-lactalbumin molten globule and weakens its cooperativity of folding. Proc. Natl. Acad. Sci. USA. 96, 11283\u201311287 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2951_CR20","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","volume":"391","author":"P Caraceni","year":"2018","unstructured":"Caraceni, P. et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet 391, 2417\u20132429 (2018).","journal-title":"Lancet"},{"key":"2951_CR21","first-page":"2884","volume":"74","author":"T Kamada","year":"1997","unstructured":"Kamada, T. et al. \u809d\u786c\u5909\u306b\u3088\u308b\u8179\u6c34\u306b\u5bfe\u3059\u308bGB-1057 (\u4eba\u8840\u6e05\u30a2\u30eb\u30d6\u30df\u30f3\u3014\u7d44\u63db\u3048\u578b\u3015) \u3068\u8840\u6f3f\u7531\u6765\u4eba\u8840\u6e05\u30a2\u30eb\u30d6\u30df\u30f3\u306e\u591a\u65bd\u8a2d\u7fa4\u9593\u6bd4\u8f03\u8a66\u9a13 (in Japanese). Rinsho To Kenkyu 74, 2884\u20132899 (1997).","journal-title":"Rinsho To Kenkyu"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02951-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02951-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02951-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:38:19Z","timestamp":1789742299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02951-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2951"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02951-7","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.J.A., F.Z.L., L.R.F., Y.W.L., X.B.X., R.Y., L.S., and T.G. are employees of Shenzhen Protgen Co., Ltd., and Y. Luo is a shareholder of Protgen. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"390"}}